FIELD: pharmaceutics.
SUBSTANCE: invention relates to the use of carrimycin and its pharmaceutically acceptable salts for the manufacture of a medical preparation for the treatment and / or prevention of tumors. Carrimycin is a composition of spiramycin derivatives, and its main active components are isovaleryl-spiramycin I, II and III. The content of isovaleryl-spiramycin (I + II + III) is at least 60 wt%, the content of isovaleryl-spiramycin III is at least 30 wt%. In addition, the total concentration of acylated spiramycin is not less than 80 wt%, and the total amount of other unknown components does not exceed 5.0 wt%. In addition, the total concentration of spiramycin III is at least 1.0 wt%.
EFFECT: carrimycin and its pharmaceutically acceptable salts have good therapeutic effects in the treatment of breast cancer, liver cancer, lung cancer, kidney cancer, brain tumors, cervical cancer, prostate cancer, pancreatic cancer, esophageal cancer, stomach cancer, colon cancer, as well as lymphoma or leukemia.
9 cl, 49 tbl, 1 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF ISOVALERYL-SPIRAMYCIN I, II AND/OR III IN MANUFACTURE OF DRUG FOR TREATMENT AND/OR PREVENTION OF TUMOR AND PREPARATION OF DRUG | 2018 |
|
RU2766176C2 |
| RAPAMYCIN TARGET INHIBITOR IN MAMMALIAN CELLS, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019 |
|
RU2768583C2 |
| USE OF CARRIMYCIN OR ITS ACTIVE INGREDIENTS | 2019 |
|
RU2771046C2 |
| LEVOROTATORY ISOVALERYLSPIRAMYCIN 1, II, III, PREPARATIONS, METHOD FOR PREPARATION AND USE | 2011 |
|
RU2593498C2 |
| RECOMBINANT ALBUMEN WITH ANTI-CANCER EFFECT, GENE CODING IT, AND APPLICATION THEREOF | 2003 |
|
RU2333221C2 |
| PEPTIDES FROM POISON OF SCORPION Rhopalurus junceus AND PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2563348C2 |
| SELECTIVE EGFR MUTANT INHIBITOR WITH INSERTION IN EXON 20 | 2017 |
|
RU2774629C2 |
| TYPES OF COMBINED THERAPY FOR CANCER TREATMENT | 2016 |
|
RU2727474C2 |
| ANTI-c-MET DRUG CONJUGATE AND USE THEREOF | 2021 |
|
RU2822497C1 |
| MONOCLONAL ANTIBODIES TO HEPATOCYTE GROWTH FACTOR | 2004 |
|
RU2361879C2 |
